eMedicine Specialties > Neurology > Pediatric Neurology

Landau-Kleffner Syndrome

Author: Marcio Sotero de Menezes, MD, Associate Professor, Department of Neurology, Division of Pediatric Neurology, Children's Hospital of Seattle, University of Washington
Contributor Information and Disclosures

Updated: Feb 5, 2010

Introduction

Background

Acquired epileptic aphasia (AEA) typically develops in healthy children who acutely or progressively lose receptive and expressive language ability coincident with the appearance of paroxysmal EEG changes. In 1957, Landau and Kleffner initially described AEA and subsequently reluctantly agreed to the attachment of their names to the syndrome. In this article, AEA is used as a synonym for Landau-Kleffner syndrome (LKS).

In most cases described in detail, a clearly normal period of motor and language development occurs before AEA symptoms appear. However, in the last 20 years, several reported cases have been difficult to classify because the patients' presenting symptoms appear to have been variants of those originally described. In 1 case, expressive language deteriorated instead of receptive language, whereas in another case, a brief period of normal language development (single words) was followed by language regression with abnormal EEG findings.

AEA must be differentiated from autism with minimal language regression, especially when it is associated with isolated EEG abnormalities. Many current researchers classify AEA as part of the syndrome of electrical status epilepticus of sleep (ESES), which is also known as continuous spike and wave of slow-wave sleep.

Pathophysiology

Whether seizures and epileptiform discharges cause language dysfunction in AEA is disputed. Aphasia and EEG abnormalities might have a common cause, for example, a left temporal brain astrocytoma or head injury. Some speculate that reinforcement of synaptogenesis mediates the neurologic deficits in AEA and that epileptiform discharges during a critical period of synaptic reinforcement or pruning in turn mediate the reinforcement of synaptogenesis.

Concrete substantiation of this hypothesis is the existence of poor speech in patients who are affected early and who do not respond to anticonvulsant measures. Some patients with AEA appear to have worsened language skills during periods of increased epileptiform activity. However, many reports describe no correlation between EEG abnormality and language dysfunction.

Most cases of AEA are spontaneous, though familial clustering has been reported. Descriptions of monozygotic twins include cases in which AEA affects only 1, cases in which AEA affect both, and cases in which AEA affects 1 and developmental dysphasia affects the other. These cases cast serious doubt on the role of epilepsy in speech dysfunction.

Frequency

United States

Population-based epidemiologic data related to AEA are limited. The Children's Hospital and Medical Center (Seattle, WA) treats 1-2 new cases of AEA each year.

International

More than 200 cases have been described in global literature. In 1957-1980, 81 cases of AEA were reported. More than 100 cases are documented every 10 years. Numbers are difficult to report because patients may be repeated in various series, as switching professional care is common because of the patient's and family's frustration with aggressive treatment that does not improve the patient's speech. An urban Israeli pediatric neurology clinic reported a 0.2% rate of AEA.

Sex

A slight predominance in boys is noted, with a male-to-female ratio of 1.7:1.

Age

Aphasia usually appears at 4-7 years of age. However, symptom onset has been described in patients as young as 18 months and in those as old as 13 years. This discussion excludes the congenital cases with typical EEG patterns and little or no language development; in such cases, the precise age of onset can never be determined.

Early Language Development: In the early descriptions of the syndrome, language dysfunction was not recognized in the early-acquisition phase in the first 18 months of life. In the last 10 years, scrutiny of the language development has revealed some minor abnormalities. In 1994, Soprano et al found signs of developmental dysphasia in 9 of 12 cases.1 In 2001, Robinson et al reported language delay in 4 of 18 cases.2

Clinical

History

  • Language symptoms
    • The first manifestation of the language problem is often word deafness or auditory verbal agnosia. In many patients, auditory verbal agnosia may include lack of recognition of familiar noises; however, alert responses to sound and tonal audiograms are usually normal. In some patients, even the capability of lateralizing and/or localizing sound may be impaired. Receptive language is often severely or profoundly impaired as a result of an interference with phonologic decoding. Although the primary problem is in the receptive sphere, this syndrome appears in a critical period of language acquisition; therefore, speech production may be affected just as badly as or even worse than language comprehension. This is often the case as the disease progresses.
    • In some cases, impairment may be most severe in expressive language. In 1 study, aphasia was predominantly expressive in 6 of 77 patients who appeared to have AEA.
    • Reading and writing may be remarkably preserved in children with little speech or auditory comprehension, and these children can be taught lip reading and writing as well. Speech disturbances may include fluent aphasia, use of jargon and paraphrase, asyntaxia, and verbal stereotypies in children who are not completely mute. Some abnormalities may superficially resemble autism or psychosis, common diagnoses given to children with AEA.
    • The age of onset of aphasia is between 18 months and 13 years, but usually after 4 years and before 7 years. A few authors include in the definition of AEA patients with limited or no language development associated with paroxysmal EEG. In such cases, being certain about the true age of onset of symptoms is difficult. Some authors have included cases of developmental dysphasia associated with seizure-related fluctuations in speech performance, whereas others have not. Further studies are necessary to determine if the response to treatment really differs to justify this separation.
    • Language deterioration commonly occurs over weeks or months, but acute onset after a seizure has also been described. Intermittent/episodic aphasia may be seen as well.
    • The present author found that 40% of patients referred for workup of language deterioration actually had other problems. In 2, a history of language deterioration was not given during the first visit to the neurology clinic; however, over time, the parents' perception of the problem changed. This change may have been due to the desire to give the child the benefit of doubt in the evaluation to differentiate AEA from autism. This parental perception springs from the notion that AEA can be treated but that autism or pervasive developmental disorder (PDD) cannot. However, this belief does not reflect the reality of the difficulties in treating AEA.
    • Course of language dysfunction and its relationship with paroxysmal EEG abnormalities
      • No consensus exists concerning the relationship between discharges on the EEG and the presence and intensity of language problems.
      • In many cases, continuous spike and wave during sleep seems to precede language deterioration.
      • Improvement in the paroxysmal EEG pattern during sleep often precedes the clinical language improvement.
      • Several authors have found that aphasia is correlated with unilateral or bilateral temporal-lobe discharges or with periods of 1 or more years of continuous bilateral spike-wave of slow sleep when language appears to worsen.3
    • Others found this correlation to be far from reliable. Soprano et al observed persistent EEG abnormalities in patients with poor language recovery, but 6 of 9 with EEG normalization remained aphasic.1
    • The relationship between aphasia and paroxysmal EEG may not be an "on-off" response. Several factors limit the reliability of the EEG data, as follows:
      • Neurologic deficits do not closely follow the maximal EEG changes in time. Patients with unilateral motor weakness related to a seizure (Todd paralysis) often remain weak for hours, and in rare cases days, after a partial seizure is gone.
      • Repeated and long seizures are most often associated with long postictal dysfunction, which, at some point, may not recover completely.
      • Attenuation of the electrical activity of brain as it goes through the skull (see the EEG and Magnetoencephalography in Other Tests). This is especially true if the localization of the epileptiform activity is deep and has a tangential orientation.
      • The assumptions that paroxysmal EEG may or may not be correlated with the aphasia fluctuation also may be flawed because, if epileptic and/or neurotoxic brain damage is present in AEA, recovery from this damage may take time or may never happen. Two findings—that some patients improve with the use of corticosteroids or adrenocorticotropin hormone (ACTH) and that patterns on angiograms resemble those seen in cerebral arteritis—suggest that inflammation and vasospasm may play a role in some cases of AEA. This phenomenon is probably not universal because not all patients show EEG or clinical response to steroids and 2 neuropathologic specimens from temporal lobectomies revealed no inflammatory changes.
  • Seizures
    • The prevalence of clinical seizures in AEA is 70-85%. In one third of patients, only a single seizure (or episode of status epilepticus) is recorded. In about one half, a seizure is the initial manifestation of AEA. In some, a few years may pass between the first seizure and the onset of any speech problems, whereas the opposite is true in others. Seizures usually appear between 4 and 10 years of age, and many series show that remission of the seizures before adulthood (often before age 15 y) is the rule.
    • Clinical seizures are often easy to treat, but normalization of EEG discharges can be challenging. Among patients in whom ictal semiology is well described, 59% had partial seizures, 39% had generalized tonic-clonic seizures, and 16% had atypical absences. Myoclonic seizures involving the face and eyes have been described. About 12% of patients have a family history of epilepsy.
  • Behavioral and neuropsychological disturbances
    • Behavioral disturbances are seen in as many as 78% of the patients. Some patients may appear deaf or autistic. The diagnosis of autism is often considered because of the common presence of asyntaxia, parapsias, and verbal stereotypies. Hyperactivity and a decreased attention span are observed in as many as 80% of patients. Aggressive and oppositional behavior, including rage attacks, is not unusual. The aggression and rage may be so prominent that the patients may be admitted to a psychiatric service rather than a neurologic service, either initially or during the course of the disease. Anxiety and avoidant or bizarre behavior may also be seen.
    • Although behavior patterns are thought to be secondary to the language impairment, some patients may have complex, hard-to-explain, and bizarre behaviors, such as avoidance of interpersonal contact and gestural stereotypies. In some cases, frankly psychotic behavior has been described. As already mentioned, autism and/or psychosis are often suspected in these patients.
    • Other aspects of cognition are traditionally said to be preserved, but a discrepancy between nonverbal and verbal skills is sometimes seen. Diffuse neuropsychological deficits may appear over time. Short-term memory is a debilitating feature seen in long-standing cases.
  • Controversial features
    • Some cases initially thought to be benign childhood epilepsy with centrotemporal spikes later develop into a picture of AEA.
    • In addition, some patients with early-onset benign childhood occipital epilepsy (Panayiotopoulos type) syndrome have language dysfunction because of the continuous spike-and-wave discharges during slow-wave sleep.

Physical

  • Mental status examination of patients with AEA demonstrates language, speech, and behavior problems, as described in the History section above.
  • A history of a poor understanding of spoken language should be substantiated by performing objective testing of all aspects of the patient's speech and language, such as his or her comprehension, repetition, reading, and writing.
  • Bedside and/or office testing of language skills should be supplemented by formal neuropsychological testing.
  • Besides language, speech, and behavior, physical and neurologic examination of patients with AEA shows motor clumsiness or, less frequently, apraxia. In some cases, frank abnormalities of tone and motor function are noted, but these findings are the exceptions rather than the rule.
  • Patients with AEA secondary to a tumor, stroke, or head injury commonly have hemiparesis (usually right sided).
  • Signs of increased intracranial pressure, such as papilledema and, in more extreme cases, erratic respirations, bradycardia, and hypertension, should alert the clinician to the possibility of a mass lesion.

Causes

  • Most cases of AEA do not have a well-defined cause.
  • A few cases of secondary AEA have been described.
    • Low-grade brain tumors, closed-head injury, neurocysticercosis, and demyelinating disease have been associated with the clinical picture of AEA.
    • CNS vasculitis may also be associated with AEA.
    • One case of otherwise typical AEA has been described in association with mitochondrial respiratory chain complex I deficiency.
    • Bilateral perisylvian polymicrogyria may also present with new onset of speech disturbance after a 2-year period of normal language and EEG findings typical of AEA.
  • Other diagnostic considerations might be warranted.
    • The differential diagnosis of AEA is extensive. Acquired aphasia in children may be secondary to head trauma, brain tumors, stroke, or neurocysticercosis. Like AEA, head injury, brain neoplasms, and cerebrovascular thromboembolism may be associated with an epileptiform EEG and seizures. Other neurologic deficits, such as hemiparesis or signs of increased intracranial pressure, may be a clue of an underlying structural lesion. Images, especially MRIs, clarify the diagnosis. Patients with brain tumors may develop an acquired aphasia secondary to seizures and epileptic discharges generated around the neoplasm.
    • Deaf children may have many of the symptoms of AEA. Conversely, patients with AEA do not always have convulsions, and, even when present, the seizures may be missed. Some children with AEA may initially be thought to be deaf and are referred for audiologic evaluation.
    • Hyperactivity and decreased attention span are common in AEA. Patients in whom attention deficit disorder is suspected should be carefully examined for aphasia. The resemblance of AEA and attention deficit disorder is superficial, and differentiation of the 2 should not be difficult. Likewise, patients with aggressive (eg, rage attacks), oppositional, or psychotic behavior should be examined for signs of language impairment because these symptoms can be present in patients with AEA.
    • Complex and bizarre behaviors, such as interpersonal contact avoidance, gestural stereotypies, and frankly autistic behavior can be seen in AEA. A careful history is necessary in patients with autism or PDD. When in doubt, a sleep EEG is required to rule out AEA.
    • Patients who never develop language or have a poor acquisition of language must be differentiated from children with hearing deficits and mental retardation. AEA and mental retardation (congenital without intellectual deterioration) should be differentiated on the basis of information from the history, neuropsychological testing, and EEG. Patients with AEA typically have normal hearing threshold on formal testing.
    • On occasion, patients with neurodegenerative diseases may present with problems in language comprehension. This is especially true for patients with adrenoleukodystrophy in whom the initial complaint can be difficulty in processing auditory information due to dysmyelination of the white matter in the temporoparietal region. At this stage, patients do not necessarily have corticospinal tract signs; however, over time, spasticity, increased deep tendon reflexes, and upgoing toes become apparent. Seizures are infrequent (about 10%) in adrenoleukodystrophy. The age of onset of the childhood form of adrenoleukodystrophy is similar to that of AEA. T2-weighted MRIs of the brain show increased signal intensity in the affected areas.
    • Table 1. Epileptiform EEG Findings in Autism, Dysphasia, and Epilepsy

      Open table in new window

      [ CLOSE WINDOW ]
      Table
      ReferenceDiagnosisNo. of PatientsNo. of Patients with EEGsPatients with Abnormal EEGs (%)
      Tuchman, 1991Autism with epilepsy42
      		40
      		75
      Autism without epilepsy160
      		139
      		8
      Dysphasia with epilepsy19
      		19
      		58
      Dysphasia without epilepsy218
      		66
      		9
      Tuchman and Rapin, 1997PDD or autism585
      		392*
      		NA
      With epilepsyNA
      		66
      		59
      Without epilepsyNA
      		66
      		59
      Without epilepsy but with history of regressionNA
      		155
      		14
      Without epilepsy and without history of regressionNA
      		364
      		6
      ReferenceDiagnosisNo. of PatientsNo. of Patients with EEGsPatients with Abnormal EEGs (%)
      Tuchman, 1991Autism with epilepsy42
      		40
      		75
      Autism without epilepsy160
      		139
      		8
      Dysphasia with epilepsy19
      		19
      		58
      Dysphasia without epilepsy218
      		66
      		9
      Tuchman and Rapin, 1997PDD or autism585
      		392*
      		NA
      With epilepsyNA
      		66
      		59
      Without epilepsyNA
      		66
      		59
      Without epilepsy but with history of regressionNA
      		155
      		14
      Without epilepsy and without history of regressionNA
      		364
      		6
      Note.—NA = not applicable.
      * Sleep EEGs.
    • The rest of this section discusses various syndromes related to AEA.
  • Oromotor-expressive language deficit associated with a centrotemporal epileptic focus (acquired expressive epileptic aphasia)
    • A rare syndrome has been described in which patients appear to have a primarily expressive language deficit associated with a centrotemporal epileptic focus. Temporary speech and oromotor disturbances may be seen in this syndrome. Voluntary oromotor functions and speech production may be affected depending on the location and spread of the epileptic discharges (more anterior or posterior in the perisylvian region). Like those in AEA, these deficits can occur as initial symptoms of the disorder without visible seizures. The range of symptoms in these patients goes from nonlinguistic deficits, such as intermittent drooling to oromotor apraxia, disfluency, and (in severe cases) full-blown anterior opercular syndrome.
    • Oromotor apraxia and speech problems may be congenital, or they may develop or worsen with episodes of sustained spike and wave discharges during sleep. Seizures are nocturnal and either orofaciobrachial partial or secondarily generalized. The ages of onset, progression, and recovery of the deficits are variable but depend on the degree and duration of epileptic activity. The EEG in this syndrome shows rolandic (ie, centrotemporal) discharges, which are commonly bilateral.
    • During sleep, continuous spike and wave discharges may be seen on the EEG and, that pattern may be correlated with clinical deterioration. One family with this syndrome had autosomal dominant transmission with anticipation for the seizure disorder, oral and/or speech dyspraxia, and cognitive dysfunction, raising the possibility of a triplet repeat syndrome.4 Antiepileptic medication and a ketogenic diet may affect the course of the disease in some cases.
  • Developmental dysphasia or developmental expressive language disorder
    • Developmental dysphasia is a syndrome in which language acquisition does not occur despite normal intelligence and the lack of brain or hearing pathology. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) refers to this syndrome as developmental expressive language disorder, a more appropriate term than developmental dysphasia because it considers the poor development or lack of acquisition of expressive language.
    • Overnight sleep recording in patients with developmental dysphasia may show epileptiform discharges; in one study, as many as 30 of 32 cases studied had these discharges even though half of the patients studied never had a seizure. The EEG abnormalities in developmental dysphasia may be more prominent during sleep, but one study found only minimal or no worsening in the transition from sleep stages 1-2 to 3-4 (slow-wave sleep).
    • Other investigators have described patients with developmental expressive language disorder and epileptiform EEGs, which suggests that these cases are "congenital variants of the Landau-Kleffner syndrome (AEA)." As can be concluded from the name of this disorder, the main problem is with expressive language, whereas in classic AEA the primary problem is in the receptive sphere. Nonetheless, differentiation between this disorder and AEA may be difficult for the following reasons:
      • In AEA the primary problem is in the receptive sphere, but speech production may be affected just as badly or even worse than language comprehension.
      • An expressive-aphasia variant of AEA is known.
      • Cases of AEA and developmental dysphasia can be seen in the same pedigree, including one report of discordant monozygotic twins, suggesting a similar genetic abnormality with different phenotypes.
      • Many patients with developmental dysphasia also have EEG abnormalities, and 3 cases seemed to respond to ACTH therapy.
    • Because of these arguments, clinicians should be open to the possibility that some patients with developmental expressive language disorder may have abnormal EEGs and that they occasionally respond to treatments used for AEA. Differentiation of developmental expressive language disorder (developmental dysphasia) and acquired expressive epileptic aphasia (oromotor-expressive language deficit associated with centrotemporal epileptic focus) with an early onset of symptoms is difficult and may be impossible in many cases.
  • AEA and autism
    • Autism is a strong consideration in patients presenting with an AEA-like picture. Not all patients with AEA have seizures, and some patients with autism may have EEG abnormalities with or without seizures. As mentioned earlier, many families change their perception of the patient's history over time. In these cases, consulting the child's initial medical records to obtain the correct information is helpful. In that sense, retrospective analysis, especially if the initial consultation notes are not accessible, may overestimate the incidence of language regression in these patients.
    • The diagnosis of autism (autistic disorder) based on criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) is divided in 3 subgroups: (1) impairment of reciprocal social interaction, (2) qualitative impairment in verbal and nonverbal communication as well as imaginative activity, and (3) markedly restrictive repertoire of activities and interests. PDD is diagnosed when qualitative impairment of reciprocal social interaction and verbal and nonverbal communication skills is present without fulfillment of the criteria for autistic disorder, schizophrenia, or schizotypal or schizoid personality disorder.
    • History of language regression is not unusual in autism and obtained retrospectively in as many as 39% of children with autism and prospectively in one third of patients with either autism or PDD. Language regression occurs equally among children with autism or PDD with or without epilepsy. Children with low cognitive function are more likely to have undergone regression than those with better cognitive skills (34% vs 20%). The age at which language regression occurs (ie, before or after 2 y) makes no difference in the proportion of children with epileptiform EEGs.
    • The frequency of overt epilepsy among patients with autism or PDD is 7.6-25%. This range partly depends on the definitions of autism and PDD and on how strictly these criteria are applied. Epilepsy is common among male patients, and the seizures start in the first year of life in more than 80% of the patients. Tuchman et al found that epilepsy was present in 14% of autistic children after they excluded patients with Rett syndrome. Other authors have reported higher frequencies than this among patients with autism.
    • The relationship between autism, epileptiform EEG, epilepsy, and language regression is complex and only partially understood. In a study in which 60% of an autistic population underwent EEG, about 22% had epileptiform abnormalities. In approximately one half of the children in whom EEG demonstrated epileptiform discharges, the discharges were located over the centrotemporal region, regardless of whether the child was epileptic or had regression. Two explanations are possible: One is that patients have comorbidity of benign (rolandic) epilepsy with centrotemporal spike-EEG trait with autistic symptoms (eg, benign epilepsy with centrotemporal spikes, one of the most prevalent epileptic syndromes). The second explanation tries to attribute a cause-effect relationship between the epileptiform abnormalities and the autistic and language regression symptoms.
    • Tuchman and Rapin prospectively studied language regression in patients with PDD and found that, in nonepileptic autistic children, a history of regression was associated with a 2-fold increase in the incidence of epileptiform EEG (P = .0095, 2-tailed chi-square test) compared with those who had not undergone regression and had no seizures. The proportion of children with epilepsy or epileptiform EEGs who had regression before or after age 2 years did not differ.5
    • The subgroup of patients with autism, language regression, and epileptiform EEGs has been described as having autistic epileptiform regression. Patients in this group also have regression of their social, nonverbal, and cognitive skills, but determining whether development was completely normal before the regression is often difficult. All of the studies were biased because of the lack of universal EEG performance in patients with autism or PDD or the lack of prolonged-sleep tracing in patients with PDD.
    • The types of seizures most commonly associated with autism are infantile spasms, complex partial seizures, and generalized tonic-clonic convulsions. About one third of autistic patients with epilepsy have (or had) infantile spasms or myoclonic seizures. Severe mental retardation and motor deficit appear to be associated with an increased incidence of epilepsy in autistic patients. A high incidence of epilepsy occurs in patients with deficit in oral comprehension or verbal auditory agnosia. This finding is not unexpected because it is probably due to inclusion of patients with AEA and its variants, which all can demonstrate autistic features.
  • AEA and the syndrome of continuous spike-wave during slow sleep
    • One of the main differential diagnoses of AEA is the syndrome of continuous spike-wave during slow sleep, or ESES. In fact, some authors consider AEA as part of the ESES spectrum. A few features may help differentiate ESES from AEA. In ESES, nocturnal spike and wave discharges by definition occupy more than 85% of slow-wave sleep (stages 3 and 4 non–rapid eye movement [REM]), especially during the first sleep cycle, but become focal during REM sleep. In AEA, on the other hand, generalized spike-and-wave discharges may continue to be maximal or be seen only during REM. The EEG in ESES may show frontal or frontocentral location of focal discharges, but in AEA the focal discharges often show temporal or parietal distribution.
    • The use of the source localization of the focal discharges for the differentiation of these two syndromes (AEA and ESES) has limited value since well-documented ESES cases may have primary parietal generators for secondary generalized discharges. In many cases, the generalized discharges seen in ESES also represent secondary bilateral synchrony from a consistently unilateral focus, which can be located in either hemisphere. The seizures seen in patients with ESES are similar to the ones of AEA, but drop attacks and myoclonic and unilateral clonic seizures may be more common in ESES. The nature of the cognitive deterioration is more diffuse in ESES than in AEA.
    • Besides substantial language problems, patients often have reduced temporal-spatial orientation and memory function during the active phase of ESES. As measured by using the Wechsler intelligence scales for children (WISC), cognition (ie, intelligence quotient [IQs]) severely declines. Verbal scores on the WISC are affected more than performance scores. The term disintegrative epileptiform disorder has been used in reference to patients with normal development in whom deterioration of language, sociability, nonverbal communication, and cognition occurs after age 2 years in association with an epileptiform EEG, often with an ESES pattern.
  • Childhood disintegrative disorder
    • Regression of language, cognition, and behavior after age 2 years has been classified as disintegrative disorder. The definition of the term is still in flux. Rapin suggests that the term should be used for patients with autistic regression with onset after age 2 years. The DSM-IV defines childhood disintegrative disorder as loss of language, social, adaptive, and play skills between the ages of 2 and 10 years after normal development in these areas before the age of 2 years. DSM-IV criteria require abnormal functioning in at least 2 of the following areas:
      • Social interaction
      • Verbal and nonverbal communication and make-believe play
      • Stereotyped behavior, interests, activities, mannerisms, and stereotypies
    • DSM-IV diagnostic criteria of childhood disintegrative disorder require the clinician to rule out any of the other PDDs, schizophrenia, and other dementing medical conditions (eg, adrenoleukodystrophy, metachromatic leukodystrophy). The DSM-IV criteria do not specifically mention differentiation on the basis of EEG. The term disintegrative epileptiform disorder has been used to describe patients with normal development who present with deterioration of language, verbal and/or nonverbal communication, sociability, and cognition after age 2 years associated with an epileptiform EEG.
    • The EEG abnormality is often ESES with frontal predominance. The latter may be differentiated by widespread deterioration of cognition, as opposed to the picture of AEA, which affects mostly language, at times with secondary behavioral changes. Differentiation between disintegrative epileptiform disorder and ESES may be impossible on clinical and EEG grounds owing to the variability of the behavioral and cognitive findings in ESES.
    • Table 2. Differential Diagnosis of Syndromes of Language and/or Cognitive and Behavioral Regression

      Open table in new window

      [ CLOSE WINDOW ]
      Table
      DiagnosisDeteriorationEEG Patterns
      Autistic epileptiform regressionExpressive language, RL, S, verbal and nonverbal communicationCentrotemporal spikes
      Autistic regressionExpressive language, RL, S, verbal and nonverbal communicationNormal
      AEARL, possibly behavioralL or R temporal or parietal spikes, possibly ESES*
      Acquired expressive epileptic aphasiaExpressive language, oromotor apraxiaCentrotemporal spikes
      ESESExpressive language, RL, possibly behavioralESES*
      Developmental dysphasia (developmental expressive language disease)No, lack of expressive language acquisitionTemporal or parietal spikes
      Disintegrative epileptiform disorderExpressive language, RL, S, verbal and nonverbal communication, possibly behavioralESES*
      DiagnosisDeteriorationEEG Patterns
      Autistic epileptiform regressionExpressive language, RL, S, verbal and nonverbal communicationCentrotemporal spikes
      Autistic regressionExpressive language, RL, S, verbal and nonverbal communicationNormal
      AEARL, possibly behavioralL or R temporal or parietal spikes, possibly ESES*
      Acquired expressive epileptic aphasiaExpressive language, oromotor apraxiaCentrotemporal spikes
      ESESExpressive language, RL, possibly behavioralESES*
      Developmental dysphasia (developmental expressive language disease)No, lack of expressive language acquisitionTemporal or parietal spikes
      Disintegrative epileptiform disorderExpressive language, RL, S, verbal and nonverbal communication, possibly behavioralESES*
      * Continuous spike and wave of slow-wave sleep (>85% of slow-wave sleep).
      † R indicates receptive language; S, sociability.

More on Landau-Kleffner Syndrome

Overview: Landau-Kleffner Syndrome
Differential Diagnoses & Workup: Landau-Kleffner Syndrome
Treatment & Medication: Landau-Kleffner Syndrome
Follow-up: Landau-Kleffner Syndrome
References
[ CLOSE WINDOW ]

References

  1. Soprano AM, Garcia EF, Caraballo R, Fejerman N. Acquired epileptic aphasia: neuropsychologic follow-up of 12 patients. Pediatr Neurol. Oct 1994;11(3):230-5. [Medline].

  2. Robinson RO, Baird G, Robinson G, Simonoff E. Landau-Kleffner syndrome: course and correlates with outcome. Dev Med Child Neurol. Apr 2001;43(4):243-7. [Medline].

  3. Rousselle C, Revol M. Relationship between cognitive function and CSWS. In: Beaumanoir A, Bureau M, Deona T, et al, eds. Continuous Focal Spikes During Slow Sleep or ESES. London, England: John Libbey;. 1995: 123-33.

  4. Scheffer IE, Jones L, Pozzebon M, et al. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann Neurol. Oct 1995;38(4):633-42. [Medline].

  5. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics. Apr 1997;99(4):560-6. [Medline]. [Full Text].

  6. Beaumanoir A. The Landau-Kleffner Syndrome. In: Roger J, Dravet C, Bureau M, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence. 2nd ed. London, England: John Libbey Eurotext;. 1992:231-43.

  7. Paetau R, Kajola M, Korkman M, et al. Landau-Kleffner syndrome: epileptic activity in the auditory cortex. Neuroreport. Apr 1991;2(4):201-4. [Medline].

  8. Paetau R. Magnetoencephalography in Landau-Kleffner syndrome. Epilepsia. Aug 2009;50 Suppl 7:51-4. [Medline].

  9. Pascual-Castroviejo I, Lopez Martin V, Martinez Bermejo A, Perez Higueras A. Is cerebral arteritis the cause of the Landau-Kleffner syndrome? Four cases in childhood with angiographic study. Can J Neurol Sci. Feb 1992;19(1):46-52. [Medline].

  10. Arts WF, Aarsen FK, Scheltens-de Boer M, Catsman-Berrevoets CE. Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins. Epilepsia. Aug 2009;50 Suppl 7:55-8. [Medline].

  11. Morrell F, Whisler WW, Smith MC, et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain. Dec 1995;118 ( Pt 6):1529-46. [Medline].

  12. Sawhney IM, Robertson IJ, Polkey CE, et al. Multiple subpial transection: a review of 21 cases. J Neurol Neurosurg Psychiatry. Mar 1995;58(3):344-9. [Medline].

  13. Duran MH, Guimaraes CA, Medeiros LL, Guerreiro MM. Landau-Kleffner syndrome: long-term follow-up. Brain Dev. Jan 2009;31(1):58-63. [Medline].

  14. Aicardi JI. Landau-Kleffner syndrome and syndrome of continuous spike-wave during slow sleep. In: Aicardi JI, ed. Epilepsy in Children. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:176-87.

  15. Aicardi JI. Syndrome of acquired aphasia with seizure disorder (epileptic aphasia, Landau-Kleffner syndrome, verbal auditory agnosia with convulsive disorder) and continuous spike-wave during slow sleep (electrical status epilepticus of slow sleep). In: Aicardi JI. Epilepsy in Children. 2nd ed. New York, NY: Raven;1994.

  16. Appleton RE. The Landau-Kleffner syndrome. Arch Dis Child. May 1995;72(5):386-7. [Medline].

  17. Autret A, Lucas B, Hommet C, et al. Sleep and the epilepsies. J Neurol. Apr 1997;244(4 Suppl 1):S10-7. [Medline].

  18. Aykut-Bingol C, Arman A, Tokol O, et al. Pulse methylprednisolone therapy in Landau-Kleffner syndrome. doi:10.1016/0896-6974(96)00026-6. J Epilepsy. 1996;9:189-91.

  19. Bates E, Thai D, Janowsky JS. Early language development and its neural correlates. In: Segalowitz SJ, Rapin I, eds. Child Neuropsychology (Pt 2). 1992: 69-110.

  20. Beaumanoir A. The Landau-Kleffner syndrome. In: Roger J, Dravet C, Bureau M, eds. Epileptic Syndromes in Infancy, Childhood, and Adolescence. London, England: John Libbey Eurotext;. 1985: 181-91.

  21. Billard C, Autret A, Lucas B, et al. Are frequent spike-waves during non-REM sleep in relation with an acquired neuro-psychological deficit in epileptic children?. Neurophysiol Clin. Dec 1990;20(6):439-53. [Medline].

  22. Bishop DV. Age of onset and outcome in ''acquired aphasia with convulsive disorder'' (Landau-Kleffner syndrome). Dev Med Child Neurol. Dec 1985;27(6):705-12. [Medline].

  23. Bourgeois BF. Clinical aspects of epilepsy including diagnosis, management, pharmacotherapy, and surgery. Curr Opin Neurol Neurosurg. Apr 1993;6(2):233-9. [Medline].

  24. Caraballo RH, Astorino F, Cersosimo R, et al. Atypical evolution in childhood epilepsy with occipital paroxysms (Panayiotopoulos type). Epileptic Disord. Sep 2001;3(3):157-62. [Medline].

  25. Cole AJ, Andermann F, Taylor L, et al. The Landau-Kleffner syndrome of acquired epileptic aphasia: unusual clinical outcome, surgical experience, and absence of encephalitis. Neurology. Jan 1988;38(1):31-8. [Medline].

  26. da Silva EA, Chugani DC, Muzik O, Chugani HT. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature. J Child Neurol. Nov 1997;12(8):489-95. [Medline].

  27. Deonna T, Beaumanoir A, Gaillard F, Assal G. Acquired aphasia in childhood with seizure disorder: a heterogeneous syndrome. Neuropadiatrie. Aug 1977;8(3):263-73. [Medline].

  28. Deonna TW. Acquired epileptiform aphasia in children (Landau-Kleffner syndrome). J Clin Neurophysiol. Jul 1991;8(3):288-98. [Medline].

  29. Deonna TW, Roulet E, Fontan D, Marcoz JP. Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes (BPERS). Relationship to the acquired aphasia-epilepsy syndrome. Neuropediatrics. Apr 1993;24(2):83-7. [Medline].

  30. Doose H. EEG in Childhood Epilepsy: Initial Presentation and Long-term Follow Up. London, England: John Libbey Eurotext;. 2003.

  31. Dugas M, Grenet P, Masson M, et al. [Childhood aphasia with epilepsy. Remission with antiepileptic treatment]. Rev Neurol (Paris). Jul 1976;132(7):489-93. [Medline].

  32. Dugas M, Masson M, Le Heuzey MF, Regnier N. Childhood acquired aphasia with epilepsy (Landau-Kleffner syndrome): 12 personal cases [in French]. Rev Neurol (Paris). 1982;138(10):755-80. [Medline].

  33. Durand JM. About systemic lupus erythematosus and thrombotic thrombocytopenic purpura [comment]. Lupus. 1998;7(4):235. [Medline].

  34. Duvelleroy-Hommet C, Billard C, Lucas B, et al. Sleep EEG and developmental dysphasia: lack of a consistent relationship with paroxysmal EEG activity during sleep. Neuropediatrics. Feb 1995;26(1):14-8. [Medline].

  35. Echenne B, Cheminal R, Rivier F, et al. Epileptic electroencephalographic abnormalities and developmental dysphasias: a study of 32 patients. Brain Dev. Jul 1992;14(4):216-25. [Medline].

  36. Fayad MN, Choueiri R, Mikati M. Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia. Apr 1997;38(4):489-94. [Medline].

  37. Feekery CJ, Parry-Fielder B, Hopkins IJ. Landau-Kleffner syndrome: six patients including discordant monozygotic twins. Pediatr Neurol. Jan-Feb 1993;9(1):49-53. [Medline].

  38. Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign localization-related epilepsies in children: are they predictable?. Epilepsia. Apr 2000;41(4):380-90. [Medline].

  39. Fejerman N, Engel J. Landau-Kleffner syndrome [Medlink Neurology Web site]. Available at http://www.medlink.com/medlinkcontent.asp. 2005. [Full Text].

  40. Fejerman N, Medina CS. Convulsiones en la Infancia. 2nd ed. Buenos Aires, Argentina: El Ateneo;. 1986: 201-9.

  41. Ferrie CD, Koutroumanidis M, Rowlinson S, et al. Atypical evolution of Panayiotopoulos syndrome: a case report. Epileptic Disord. Mar 2002;4(1):35-42. [Medline].

  42. Frost JD Jr, Hrachovy RA, Glaze DG. Spike morphology in childhood focal epilepsy: relationship to syndromic classification. Epilepsia. May-Jun 1992;33(3):531-6. [Medline].

  43. Gaggero R, Baglietto MG, Battaglia FM, et al. Chapter Case Reports: In: Beaumanoir A, Bureau M, Deona T, et al, eds. Continuous focal spikes during slow sleep or ESES. London, England: John Libbey;. 1995: 175.

  44. Genton P, Maton B, Ogihara M, et al. Continuous focal spikes during REM sleep in a case of acquired aphasia (Landau-Kleffner syndrome). Sleep. Oct 1992;15(5):454-60. [Medline].

  45. Glauser TA, Olberding LS, Titanic MK, Piccirillo DM. Felbamate in the treatment of acquired epileptic aphasia. Epilepsy Res. Jan 1995;20(1):85-9. [Medline].

  46. Green JB. Regarding "sounds trigger spikes in the Landau-Kleffner syndrome" by R. Paetau [comment]. J Clin Neurophysiol. Mar 1995;12(2):203. [Medline].

  47. Gross-Selbeck G. Treatment of "benign" partial epilepsies of childhood, including atypical forms. Neuropediatrics. Feb 1995;26(1):45-50. [Medline].

  48. Guerreiro MM, Camargo EE, Kato M, et al. Brain single photon emission computed tomography imaging in Landau- Kleffner syndrome. Epilepsia. Jan 1996;37(1):60-7. [Medline].

  49. Haynes RC Jr, Murad F. Adrenocorticotropic hormone, adrenocorticortical steroids and their synthetic analogs: inhibitors of adrenocorticortical steroid biosynthesis. In: Gilman AG, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 6th ed. New York, NY: Macmillan;1980:1466-96.

  50. Hirsch E, Marescaux C, Maquet P, et al. Landau-Kleffner syndrome: a clinical and EEG study of five cases. Epilepsia. Nov-Dec 1990;31(6):756-67. [Medline].

  51. Holmes GL, McKeever M, Saunders Z. Epileptiform activity in aphasia of childhood: an epiphenomenon?. Epilepsia. Dec 1981;22(6):631-9. [Medline].

  52. Huppke P, Kallenberg K, Gartner J. Perisylvian polymicrogyria in Landau-Kleffner syndrome. Neurology. May 10 2005;64(9):1660. [Medline].

  53. Janbaque I, Dulac O. Approche neuropsychologicque des epilpsies chez l'enfant. Epilepsies. 1989;1:80-5.

  54. Kale U, el-Naggar M, Hawthorne M. Verbal auditory agnosia with focal EEG abnormality: an unusual case of a child presenting to an ENT surgeon with "deafness". J Laryngol Otol. May 1995;109(5):431-2. [Medline].

  55. Kang HC, Kim HD, Lee YM. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol. Aug 2006;35(2):158-61. [Medline].

  56. Kossoff EH, Boatman D, Freeman JM. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav. Oct 2003;4(5):571-5. [Medline].

  57. Kotagal P. Secondary epileptogenesis [editorial]. J Clin Neurophysiol. Mar 1997;14(2):89. [Medline].

  58. Kramer U, Nevo Y, Neufeld MY, et al. Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients. Pediatr Neurol. Jan 1998;18(1):46-50. [Medline].

  59. Landau WM. Landau-Kleffner syndrome: an eponymic badge of ignorance [comment]. Arch Neurol. Apr 1992;49(4):353. [Medline].

  60. Lanzi G, Veggiotti P, Conte S, et al. A correlated fluctuation of language and EEG abnormalities in a case of the Landau-Kleffner syndrome. Brain Dev. Jul-Aug 1994;16(4):329-34. [Medline].

  61. Li M, Hao XY, Qing J, Wu XR. Correlation between CSWS and aphasia in Landau-Kleffner syndrome: a study of three cases. Brain Dev. May-Jun 1996;18(3):197-200. [Medline].

  62. Luat AF, Chugani HT, Asano E. Episodic receptive aphasia in a child with Landau-Kleffner Syndrome: PET correlates. Brain Dev. Oct 2006;28(9):592-6. [Medline].

  63. Marescaux C, Hirsch E, Finck S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia. Nov-Dec 1990;31(6):768-77. [Medline].

  64. Morrell F. Electrophysiology of CSWS in Landau-Kleffner syndrome. In: Beaumanoir A, Bureau M, Deona T, et al eds. Continuous focal spikes during slow sleep or ESES. London, England: John Libbey;. 1995: 77-90.

  65. Morrell F, Whisler WW, Bleck TP. Multiple subpial transection: a new approach to the surgical treatment of focal epilepsy. J Neurosurg. Feb 1989;70(2):231-9. [Medline].

  66. Nass R, Heier L, Walker R. Landau-Kleffner syndrome: temporal lobe tumor resection results in good outcome. Pediatr Neurol. Jul-Aug 1993;9(4):303-5. [Medline].

  67. Neville BG, Harkness WF, Cross JH, et al. Surgical treatment of severe autistic regression in childhood epilepsy. Pediatr Neurol. Feb 1997;16(2):137-40. [Medline].

  68. Notoya M, Suzuki S, Furukawa M, Enokido H. A case of pure word deafness associated with Landau-Kleffner syndrome: a long-term study of auditory disturbance. Auris Nasus Larynx. 1991;18(3):297-305. [Medline].

  69. Okuyaz C, Aydin K, Gucuyener K, Serdaroglu A. Treatment of electrical status epilepticus during slow-wave sleep with high-dose corticosteroid. Pediatr Neurol. Jan 2005;32(1):64-7. [Medline].

  70. Otero E, Cordova S, Diaz F, et al. Acquired epileptic aphasia (the Landau-Kleffner syndrome) due to neurocysticercosis. Epilepsia. Sep-Oct 1989;30(5):569-72. [Medline].

  71. Paquier PF, Van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or acquired aphasia with convulsive disorder: long-term follow-up of six children and a review of the recent literature. Arch Neurol. Apr 1992;49(4):354-9. [Medline].

  72. Perniola T, Margari L, Buttiglione M, et al. A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease. Epilepsia. May-Jun 1993;34(3):551-6. [Medline].

  73. Primavera A, Gianelli MV, Bandini F. Aphasic status epilepticus in multiple sclerosis. Eur Neurol. 1996;36(6):374-7. [Medline].

  74. Rapin I. Acquired aphasia in children [editorial]. J Child Neurol. Jul 1995;10(4):267-70. [Medline].

  75. Rapin I. Autistic regression and disintegrative disorder: how important the role of epilepsy?. Semin Pediatr Neurol. Dec 1995;2(4):278-85. [Medline].

  76. Riviello JJ. The Boston Children's Hospital experience with ESES and LKS course. Paper presented at: Annual Meeting of the American Epilipsy Society;. December 2006;San Diego, CA.

  77. Rossi PG, Parmeggiani A, Posar A, et al. Landau-Kleffner syndrome (LKS): long-term follow-up and links with electrical status epilepticus during sleep (ESES). Brain Dev. Mar 1999;21(2):90-8. [Medline].

  78. Roulet E, Deonna T, Gaillard F, et al. Acquired aphasia, dementia, and behavior disorder with epilepsy and continuous spike and waves during sleep in a child. Epilepsia. Jul-Aug 1991;32(4):495-503. [Medline].

  79. Shafrir Y, Prensky AL. Acquired epileptiform opercular syndrome: a second case report, review of the literature, and comparison to the Landau-Kleffner syndrome. Epilepsia. Oct 1995;36(10):1050-7. [Medline].

  80. Smith MC. Landau-Kleffner syndrome and CSWS. In: Engel JJ, Pedley TA, eds. Epilepsy: the Comprehensive CD-ROM. Philadelphia, PA:. Lippincott, Williams & Wilkins;1999.

  81. Smith MC, Hoeppner TJ. Epileptic encephalopathy of late childhood: Landau-Kleffner syndrome and the syndrome of continuous spikes and waves during slow-wave sleep. J Clin Neurophysiol. Nov-Dec 2003;20(6):462-72. [Medline].

  82. Solomon GE, Carson D, Pavlakis S, et al. Intracranial EEG monitoring in Landau-Kleffner syndrome associated with left temporal lobe astrocytoma. Epilepsia. May-Jun 1993;34(3):557-60. [Medline].

  83. Stefanatos GA. Frequency modulation analysis in children with Landau-Kleffner syndrome. Ann N Y Acad Sci. Jun 14 1993;682:412-4. [Medline].

  84. Stefanatos GA, Foley C, Grover W, Doherty B. Steady-state auditory evoked responses to pulsed frequency modulations in children. Electroencephalogr Clin Neurophysiol. Jan 1997;104(1):31-42. [Medline].

  85. Stefanatos GA, Green GG, Ratcliff GG. Neurophysiological evidence of auditory channel anomalies in developmental dysphasia. Arch Neurol. Aug 1989;46(8):871-5. [Medline].

  86. Stefanos GA, Grover W, Geller E. Case study: corticosteroid treatment of language regression in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry. Aug 1995;34(8):1107-11. [Medline].

  87. Takeoka M, Riviello JJ, Duffy FH, et al. Bilateral volume reduction of the superior temporal areas in Landau-Kleffner syndrome. Neurology. Oct 12 2004;63(7):1289-92. [Medline].

  88. Tharpe AM, Johnson GD, Glasscock ME III. Diagnostic and management considerations of acquired epileptic aphasia or Landau-Kleffner syndrome. Am J Otol. May 1991;12(3):210-4. [Medline].

  89. Tharpe AM, Olson BJ. Landau-Kleffner syndrome: acquired epileptic aphasia in children. J Am Acad Audiol. Mar 1994;5(2):146-50. [Medline].

  90. Tuchman RF. Acquired epileptiform aphasia. Semin Pediatr Neurol. Jun 1997;4(2):93-101. [Medline].

  91. Van Hirtum-Das M, Licht EA, Koh S. Children with ESES: variability in the syndrome. Epilepsy Res. Aug 2006;70 Suppl 1:S248-58. [Medline].

  92. Veggiotti P, Termine C, Granocchio E, et al. Long-term neuropsychological follow-up and nosological considerations in five patients with continuous spikes and waves during slow sleep. Epileptic Disord. Dec 2002;4(4):243-9. [Medline].

  93. Wakai S, Ito N, Ueda D, Chiba S. Landau-Kleffner syndrome and sulthiame [letter]. Neuropediatrics. Apr 1997;28(2):135-6. [Medline].

  94. Woll B, Sieratzki JS. Sign language for children with acquired aphasia [letter]. J Child Neurol. Jul 1996;11(4):347-9. [Medline].

  95. Zardini G, Molteni B, Nardocci N, et al. Linguistic development in a patient with Landau-Kleffner syndrome: a nine-year follow-up. Neuropediatrics. Feb 1995;26(1):19-25. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

acquired epileptic aphasia, AEA, verbal auditory agnosia with convulsive disorder, aphasia, LKS, electrical status epilepticus of sleep, ESES, language disorder, speech disorder, Landau-Kleffner syndrome, language development, language dysfunction, seizures, epilepsy, epileptiform discharges

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Marcio Sotero de Menezes, MD, Associate Professor, Department of Neurology, Division of Pediatric Neurology, Children's Hospital of Seattle, University of Washington
Marcio Sotero de Menezes, MD is a member of the following medical societies: American Academy of Neurology and American Epilepsy Society
Disclosure: Nothing to disclose.

Medical Editor

Robert Stanley Rust Jr, MD, MA, Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia; Chair-Elect, Child Neurology Section, American Academy of Neurology
Robert Stanley Rust Jr, MD, MA is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Headache Society, American Neurological Association, Child Neurology Society, International Child Neurology Association, and Society for Pediatric Research
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Kenneth J Mack, MD, PhD, Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic
Kenneth J Mack, MD, PhD is a member of the following medical societies: American Academy of Neurology, Child Neurology Society, Phi Beta Kappa, and Society for Neuroscience
Disclosure: Nothing to disclose.

Chief Editor

Amy Kao, MD, Assistant Professor, Department of Pediatrics, Division of Pediatric Neurology, Department of Neurology, Oregon Health and Science University; Consulting Staff, Shriners Hospital for Children
Amy Kao, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Pediatrics, American Epilepsy Society, and Child Neurology Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.